Germany's Bayer hopes that its pilot-scale production facility in
Halle, Saxony-Anhalt will help establish its tobacco plant-based
expression system as leader of the lucrative protein manufacturing
Bayer has acquired Icon Genetics in a culmination of an existing
agreement between the two companies. The deal also solidifies
Bayer's direction as it soughts to strengthen its efforts to
produce specific plant-made pharmaceuticals.
The fine chemicals business unit of Lanxess, which was spun-out
from Germany's Bayer earlier this year and provides custom
manufacturing services to the pharmaceutical and other industries,
has said it plans to expand its geographic...
German drugmaker Bayer last week put an end to speculation that it
is planning swingeing job cuts by conforming that it is planning to
axe 560 positions in Germany and the US as part of restructuring
its global pharmaceutical R&D...
Bayer's acquisition of the Roche consumer health business, a major
player in the vitamin supplements market, has been approved by the
European antitrust authorities, giving way to the creation of the
region's biggest consumer...
Germany's Bayer has reported a mixed set of results for the second
quarter with fine chemicals offshoot Lanxess contributing to an
unexpected 44 per cent hike in earnings before interest and tax
German chemical company Bayer has posted flat first-quarter 2004
sales, but said that the results were on track given the negative
effects of currency factors. Organic sales growth rose 8.6 per
cent, it claimed, and was driven mainly...
The European Court of Justice in Luxembourg has thrown out
allegations by the European Commission that Bayer, the German
pharmaceutical firm, had established a cartel agreement with its
wholesalers to restrict the trade flow of its...
Germany's Bayer has received offers to buy NewCo, the newly-created
company including parts of its chemicals and polymers divisions,
but will still go ahead with plans to float it on the stock
exchange , according to the group's...